OneMedNet Corporation (NASDAQ:ONMD – Get Free Report) Director Thomas Kosasa acquired 158,730 shares of the business’s stock in a transaction on Friday, June 12th. The shares were bought at an average price of $0.63 per share, with a total value of $99,999.90. Following the completion of the transaction, the director directly owned 17,088,874 shares of the company’s stock, valued at approximately $10,765,990.62. The trade was a 0.94% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.
Thomas Kosasa also recently made the following trade(s):
- On Monday, May 18th, Thomas Kosasa acquired 268,817 shares of OneMedNet stock. The shares were bought at an average price of $0.93 per share, with a total value of $249,999.81.
- On Thursday, April 23rd, Thomas Kosasa purchased 280,898 shares of OneMedNet stock. The shares were acquired at an average cost of $0.89 per share, for a total transaction of $249,999.22.
OneMedNet Stock Performance
NASDAQ:ONMD opened at $0.54 on Monday. OneMedNet Corporation has a 52 week low of $0.31 and a 52 week high of $4.22. The firm has a market cap of $29.58 million, a price-to-earnings ratio of -10.87 and a beta of 1.12. The firm’s 50-day simple moving average is $0.87 and its 200 day simple moving average is $0.97.
Institutional Investors Weigh In On OneMedNet
Several hedge funds have recently added to or reduced their stakes in ONMD. Jane Street Group LLC acquired a new stake in OneMedNet during the 4th quarter worth approximately $119,000. Exencial Wealth Advisors LLC boosted its position in OneMedNet by 1.3% during the 4th quarter. Exencial Wealth Advisors LLC now owns 3,644,861 shares of the company’s stock worth $4,009,000 after buying an additional 45,401 shares during the period. Virtu Financial LLC acquired a new stake in OneMedNet during the 4th quarter worth approximately $48,000. State Street Corp boosted its position in OneMedNet by 41.5% during the 4th quarter. State Street Corp now owns 116,700 shares of the company’s stock worth $128,000 after buying an additional 34,200 shares during the period. Finally, HRT Financial LP acquired a new stake in OneMedNet during the 4th quarter worth approximately $32,000. 0.95% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of research firms recently commented on ONMD. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of OneMedNet in a research report on Monday, June 1st. Wall Street Zen downgraded shares of OneMedNet from a “hold” rating to a “sell” rating in a research note on Saturday, May 23rd. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has an average rating of “Sell”.
View Our Latest Stock Analysis on OneMedNet
About OneMedNet
OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.
Read More
- Five stocks we like better than OneMedNet
- 3 ETFs Giving Ready-Made Access to the Discounted International Small-Cap Space
- What to Expect From Q2 Earnings as Tech Strength Broadens
- Viasat’s Orbiting Profits: Space Force Jackpot?
- Robinhood Wants a Bigger Role in IPOs—Here’s Why It Matters
Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.
